Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain

Samuel D. Banister, Kaavya Krishna Kumar, Vineet Kumar, Brian K. Kobilka, Sanjay V. Malhotra

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint Dive into the research topics of 'Selective modulation of the cannabinoid type 1 (CB<sub>1</sub>) receptor as an emerging platform for the treatment of neuropathic pain'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds